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Improved measurement for mothers, 
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Sustainable Development Goals
Background An urgent priority in maternal, newborn and child 
health is to accelerate the scale–up of cost–effective essential inter-
ventions, especially during labor, the immediate postnatal period and 
for the treatment of serious infectious diseases and acute malnutri-
tion.  Tracking intervention coverage is a key activity to support scale–
up and in this paper we examine priorities in coverage measurement, 
distinguishing between essential interventions that can be measured 
now and those that require methodological development.
Methods We conceptualized a typology of indicators related to inter-
vention coverage that distinguishes access to care from receipt of an 
intervention by the population in need. We then built on documented 
evidence on coverage measurement to determine the status of indica-
tors for essential interventions and to identify areas for development.
Results Contact indicators from pregnancy to childhood were iden-
tified as current indicators for immediate use, but indicators reflect-
ing the quality of care provided during these contacts need develop-
ment. At each contact point, some essential interventions can be 
measured now, but the need for development of indicators predom-
inates around interventions at the time of birth and interventions to 
treat infections. Addressing this need requires improvements in rou-
tine facility based data capture, methods for linking provider and 
community–based data, and improved guidance for effective cover-
age measurement that reflects the provision of high–quality care.
Conclusion Coverage indicators for some essential interventions can 
be measured accurately through household surveys and be used to 
track progress in maternal, newborn and child health.  Other essen-
tial interventions currently rely on contact indicators as proxies for 
coverage but urgent attention is needed to identify new measurement 
approaches that directly and reliably measure their effective coverage.
Within the 17 Sustainable Development Goals (SDGs) a total of 169 tar-
gets and over 230 indicators have been defined [1]. In alignment with the 
SDGs, the Global Strategy for Women’s, Children’s and Adolescents’ 
Health (the Global Strategy) has described an ambitious action and mea-
surement agenda around the three pillars “Survive, Thrive and Transform” 
[2]. In the immediate future many countries have an unfinished agenda 
to accelerate the scale–up of cost–effective essential maternal, newborn 
and child health (MNCH) interventions that save lives as well as help 
families to thrive [3]. Tracking intervention coverage is a top priority to 
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assist this scale–up so that countries know the extent to 
which populations in need are benefiting, and delivery 
strategies are refined as a result [4]. In this paper we exam-
ine priorities in coverage measurement of essential MNCH 
interventions, distinguishing between those that can be 
measured now and those that require methodological de-
velopment.
Of particular importance is to explicitly acknowledge 
known measurement challenges across the continuum 
from pregnancy to childhood [5–7], and categorise indica-
tors that can be measured now using existing methods and 
tools (“indicators for immediate use”), and those that are high 
priority in the context of life–saving, quality care but re-
quire further methodological development and validation 
(“priority indicators for development”). Once validated using 
feasible methods, these priority indicators for development 
can be further described in global guidance and integrated 
within existing data collection systems.
The remainder of this paper proposes a transparent set of 
evidence–based considerations for the global MNCH mea-
surement improvement agenda. We draw on evidence sup-
porting cost–effective investments in MNCH [3], recom-
mendations by the Global Strategy [8], and the priorities 
identified by other initiatives including the Global Refer-
ence List of 100 core indicators [9], the World Health Or-
ganization’s consultation on quality MNCH [10], the Every 
Newborn Action Plan (ENAP) [11], and Ending Prevent-
able Maternal Mortality (EPMM) [12].
METHODS AND CONSIDERATIONS IN 
SELECTING INDICATORS FOR 
IMMEDIATE USE
Figure 1 presents a typology of indicators related to inter-
vention coverage. Level A encompasses all women and 
children who can benefit from receiving care, including 
preventive and curative services.  From this group, only 
some will access care and have the opportunity to benefit 
from the services they need (level B). But making contact 
with services does not ensure receipt of a specific interven-
tion (level C), irrespective of whether the population mak-
ing contact needs a preventive or curative intervention. 
Currently, coverage measurement for any given interven-
tion is defined as C/A, or the proportion of women and 
children who need an intervention who actually receive it. 
The innermost element of the framework (level D) high-
lights the importance of incorporating dimensions of qual-
ity within coverage, often referred to as “effective coverage”, 
for example including measures of appropriate diagnosis, 
drug dosage, or counselling.  The need for development of 
globally standardised measures of effective coverage is de-
scribed in more detail below.
Our considerations for determining the measurement sta-
tus of indicators builds on the experience and evidence 
base generated by others, including household survey pro-
grams such as Demographic and Health Surveys (DHS) 
[13] and the Multiple Indicator Cluster Surveys (MICS) 
[14], the Countdown to 2015 for Maternal, Newborn and 
Child Survival (Countdown) initiative [15], and the invest-
ment and visibility promoted by the Commission on Infor-
mation and Accountability for Women’s and Children’s 
Health (CoIA) and its independent Expert Review Group 
(iERG) [16].
We took five characteristics into account in selecting prior-
ity indicators.
1)  Public health importance. Priority indicators should 
measure progress in coverage for an intervention that has 
the potential to save a large number of women’s and chil-
dren’s lives, because it is linked through known channels 
to changes in health status. We estimate this potential us-
ing the Lives Saved Tool (LiST) [17], calculating the 
number of maternal, newborn and child lives that could 
be saved by 2030 based on the underlying assumptions 
within the model, and if universal coverage was achieved 
for the intervention in the 75 countries that accounted 
for 99% of deaths among those groups in 2014, assum-
ing coverage trajectories for all other interventions re-
main the same (Table 1). We have included indicators 
for malaria and HIV because of their importance in some 
high burden countries, even though they do not account 
for large numbers of deaths in all countries.
2)  Feasibility and affordability. Indicators for immediate 
use must be affordable and feasible for accurate mea-
surement in the majority of high–MNCH mortality 
countries to inform immediate actions.  But high–impact 
interventions for which feasible and cost–effective mea-
surement strategies are not currently available must not 
be lost and are the target of an urgent developmental re-
search agenda, described below under priority indicators 
for development.
3)  Accuracy. Measurement approaches that do not pro-
duce valid results are a waste of scarce resources, and 
Figure 1. Typology of indicators for maternal, newborn and 
child health.
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Table 1. LiST analysis of lives saved by labor and delivery management, and life–saving interventions for mothers, newborns and 
children*
EstimatEd numbEr of dEaths avErtEd
Intervention Stillbirths Neonatal Child Maternal Total Rank
Labor & delivery management 689 758 549 031 76 850 1 315 639 1
Full supportive care for prematurity 544 458 544 458 2
Full supportive care for sepsis/pneumonia 409 877 409 877 3
Oral Rehydration Solution 12 653 369 423 382 076 4
Water connection in the home 368 313 368 313 5
Treatment with antimalarials 303 653 303 653 6
Oral antibiotics for pneumonia 300 682 300 682 7
Promotion of breastfeeding 74 699 191 976 266 675 8
Hand washing with soap 235 898 235 898 9
Neonatal resuscitation 212 439 212 439 10
Therapeutic feeding for severe wasting 209 442 209 442 11
Injectable antibiotics for neonatal sepsis/pneumonia 181 512 181 512 12
Kangaroo Mother Care 158 853 158 853 13
Syphilis detection and treatment 149 597 7 060 156 657 14
Pneumococcal vaccine 139 779 139 779 15
Improved sanitation 136 256 136 256 16
Clean postnatal practices 131 782 131 782 17
Clean birth practices 101 266 20 148 121 414 18
Treatment for moderate acute nutrition of children 110 671 110 671 19
Immediate assessment and stimulation of newborns 109 585 109 585 20
Hib vaccination 106 998 106 998 21
Zinc–for treatment of diarrhea 106 481 106 481 22
Zinc supplementation 104 426 104 426 23
Magnesium sulphate for pre–eclampsia 64 939 23 681 88 620 24
Homes protected from malaria by ownership of insecticide  
treated nets or indoor residual spraying
87 733 87 733 25
Chlorhexidine for cord care 82 283 82 283 26
Appropriate complementary feeding 80 081 80 081 27
Intermittent presumptive treatment for malaria in pregnancy 59 942 16 111 1 539 1 404 78 996 28
Oral antibiotics for neonatal sepsis or pneumonia 74 462 74 462 29
Thermal care for newborns 72 391 72 391 30
Hygienic disposal of stools 64 653 64 653 31
Periconceptual Folic Acid / Ferrous Sulfate 17 711 43 296 61 007 32
Antibiotics for premature preterm rupture of membranes 49 257 7 903 57 160 33
Rotavirus vaccine 56 788 56 788 34
Induction of labor for pregnancies beyond 42 weeks 47 230 47 230 35
Balanced energy protein supplementation for pregnant women 41 268 3309 44 577 36
Multiple micronutrients for pregnant women 39 615 2788 42 403 37
Active management of third stage of labor 33 782 33 782 38
Case management of maternal sepsis 23 528 23 528 39
Iron supplementation for pregnant women 21 964 1555 23 519 40
Diabetes case management for pregnant women 22 585 22 585 41
Magnesium sulphate for treatment of eclampsia 22 572 22 572 42
Improved water 21 470 21 470 43
Case management of hypertensive disorders in pregnant women 20 025 20 025 44
Safe abortion services 15 529 15 529 45
DPT3 vaccination 15 428 15 428 46
Tetanus toxoid vaccination 14 940 161 15 101 47
Vitamin A supplementation 14 967 14 967 48
Vitamin A–for treatment of measles 14 574 14 574 49
Post abortion case management 13 391 13 391 50
Calcium supplementation 8124 8124 51
Ectopic pregnancy case management 2980 2980 52
Case management of malaria in pregnant women 2347 2347 53
Antibiotics for dysentery 1017 1017 54
Hib – Haemophilus influenzae type B, DPT3 – diphtheria–tetanus–pertussis
*The potential number of lives saved by 54 evidence based interventions by 2030, estimated using the Lives Saved Tool if universal coverage was achieved 
for each intervention in the 75 countries that accounted for 99% of maternal, newborn and child deaths in 2014, assuming coverage trajectories for all 
other interventions remain the same.
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can misdirect policy and program decisions. There is a 
growing body of research demonstrating that mothers 
interviewed during household surveys (as in DHS or 
MICS) can report accurately on whether they and their 
children received some interventions, but not oth-
ers.  Particularly problematic are high impact interven-
tions around the time of birth and curative interventions 
for episodes of illness such as antibiotics for pneumonia 
[18–20]. New and innovative approaches for measuring 
coverage for these interventions are needed urgently, 
while maintaining support for household surveys able 
to produce highly–accurate estimates of coverage for 
most MNCH interventions. Surveys are also essential for 
assessing equity through disaggregated analyses, as re-
quired by SDG target 17.18 on the measurement of in-
equalities.
4)  Production of timely results with clear action impli-
cations. Indicator levels should change in response to 
increases or decreases in program inputs and outputs 
and improvements in program processes, within a time 
frame of one to three years, to provide information use-
ful to program managers. Experience has demonstrated 
that monitoring systems work best and are more likely 
to be sustained if the data they contain are used first at 
the level at which they are collected, and also at each 
higher level throughout the reporting system. Of impor-
tance is to encourage reporting and use of individual 
indicator components from the point of data collection 
through national level, but combining the components 
for global monitoring.
5)  Consistency with historical indicators, to permit 
tracking of trends. Lists of indicators evolve over time. 
New interventions are scaled up that require new indi-
cators, but also the validity of existing indicators may be 
challenged by new evidence. For example, the indicator 
for diarrhea management used in most surveys since the 
1990s was oral rehydration therapy (ORT), but more 
recently there has been a shift towards reporting on oral 
rehydration salts (ORS) plus zinc [21]. For the purpose 
of assessing time trends as we transition from the Mil-
lennium Development Goals (MDGs) to the SDGs it is 
useful to continue to report on ORT as well as ORS for 
a period of time, while also designing measurement 
methods so that adjustments to indicator definition can 
be made.
GETTING STARTED: INDICATORS FOR 
IMMEDIATE USE
In Figure 2 we present the contacts and interventions 
prioritized by different global groups in MNCH (for ex-
ample ENAP, EPMM, the Global Strategy), and include 
those supported by evidence of impact from LiST analysis 
(Table 1). After consideration of the five characteristics 
above these have been categorized as “current” or “prior-
ity for development”.
Contacts are included in order to measure the proportion 
of individuals accessing care, and thus potential to receive 
interventions, corresponding to level B in Figure 1. In ad-
dition to the contacts for antenatal care, skilled attendant at 
birth, and postnatal care, we also include care seeking for 
sick children (specifically fever and symptoms of childhood 
pneumonia), consistent with the typology that distinguish-
es accessing care from actual receipt of a life–saving inter-
vention. Correct treatment of these two conditions are 
among the highest–impact interventions, but cannot be 
measured accurately through household surveys. We also 
indicate the need to develop, agree on and validate indica-
tors that reflect quality care at these contact points to enable 
tracking of effective coverage measures [22]. The remainder 
of Figure 2 presents intervention indicators. High impact 
interventions are represented across the continuum from 
pregnancy to childhood and measurement development 
needs are identified at each stage. Addressing these needs 
requires immediate action, as described in the next section.
DOING BETTER: AN ACTION AGENDA 
FOR IMPROVED MEASUREMENT
Priority indicators for development predominate around in-
terventions at the time of birth, interventions to treat infec-
tions, and quality of care. Some of these represent relatively 
rare events (for example antibiotics for preterm premature 
rupture of membranes) and may never be suitable for pop-
ulation level tracking at national level, but nonetheless re-
quire advances in measurement in order to report accurate-
ly to country programs. For many, service contact indicators 
have been used to represent imperfect proxy measures of 
care but the need for measures of quality care means that 
we have to do better. For example, the service contact indi-
cator “skilled attendant at birth” is the most widely used 
proxy indicator for care at birth, but the evidence linking 
increases in skilled attendant coverage with reductions in 
mortality has not been consistent [23–25], probably reflect-
ing the fact that only a subset of locally–defined skilled at-
tendants actually have the skills, commodities and facilities 
needed to deliver essential interventions at birth.
We propose that four specific types of measurement inno-
vations are required.
First, a measurement improvement agenda is needed for 
routine data capture, so that the accuracy of reporting clin-
ical interventions for women, newborns and children is 
improved at different levels of the health system. This will 
allow delivery of high impact interventions to be tracked 
at local, national and global levels. It will require improved 
routine data systems, review and consolidation of facility 
assessment tools and methods, and engagement with 
health system strengthening efforts more broadly.
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Figure 2. Measurement status of priority contacts and evidence based interventions across the continuum from pregnancy to childhood.
Second, to realize the potential of these improved data sourc-
es, methods for linking population and provider–based data 
sources are needed [5,17]. Household survey methods pro-
vide population level data and permit equity analysis but can 
be limited by poor recall and infrequent reporting. Facility 
data can be continuous and timely, has potential to improve 
reporting on clinical events, and can be stratified by level and 
type. However, present reporting tools cannot provide ac-
curate equity breakdowns or population level estimates. 
Combining these two data streams has the potential to be 
transformative for monitoring the delivery of essential inter-
ventions that cannot currently be measured reliably, and for 
measuring effective coverage so that coverage indicators are 
defined as level D/A in Figure 1.
Third, further advances in implementation science are 
needed in order to place indicator development in the con-
text of research on the design, implementation and impact 
of large scale programs.
And fourth, as new measures and approaches are tested 
and proven ready for wider adoption, global resources and 
guidance should be developed. Resources would include 
access to questionnaires, forms, and protocols; perhaps in 
one accessible system. Global guidance would include def-
initions, strengths and limitations of potential data sources, 
and interpretation notes.
TAKING THE AGENDA FORWARD
This paper adds to other recent calls for improved mea-
surement that can enhance accountability and refine strat-
egies to save lives [26]. At this time of transition from the 
MDGs to the SDGs it is essential that baselines are estab-
lished, ambition is maintained, guidance and resources 
are shared, and momentum is not lost. Clarity about 
which essential interventions can be measured directly, 
reliably and feasibly using existing methods is an integral 
part of that plan. But here we also identify the need for 
focused, intensive commitment to advance the coverage 
measurement agenda for all essential interventions–espe-
cially those that save lives during and immediately after 
childbirth, and for sick children–so that we progress from 
reliance on measuring contacts with health care providers 
to measuring the effective coverage of clinical high–im-
pact interventions.
As we enter the SDG era, several key partners are stepping 
forward to join this global measurement agenda for mater-
nal, newborn and child health to agree on priorities, to co-
ordinate actions and learning, and to work together with 
countries so that ownership of and capacity for an im-
proved measurement agenda sits where the ability to act 
on evidence is greatest.
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